ABSTRACT
Background: The COVID-19 disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) originated from Wuhan, China, a pandemic. By knowing different demographic and clinical data, one can have a better idea about the progress and fate of disease, which will help others to plan accordingly to manage patients in terms of decreasing morbidity and mortality caused by it. Aims and Objectives: The study was done to describe the RT-PCR diagnostic profiles of SARS-CoV-2 patients in Gujarat from three districts (Arvalli, Sabarkantha, and Gandhinagar) and their correlation with respect to age, sex, travel history, symptoms, and underlying conditions. Materials and Methods: This was a retrospective cohort study of patients with COVID-19, who were screened for SARS-CoV-2 from April 16 to May 25, 2020, from three districts of Gujarat (Arvalli, Sabarkantha, and Gandhinagar). Positive cases were confirmed by qRT-PCR and analyzed for epidemiological, demographic, and clinical characterization among different groups. Results: Of 4000 suspects screened, a total of 199 patients were confirmed with SARS-CoV-2 infection. Among them, middle-aged group (5.4%) and young adult patients (4.3%) were infected with SARS-CoV-2. The median age was 33 years, including 143 males and 56 females. The positivity rate from breathlessness was 8 (28.5%), nasal discharge 2 (25%), and nausea/vomiting 2 (25%) followed by fever 28 (20%) among total cases in respective categories. Among asymptomatic 3536 patients, 146 patients were confirmed for SARS-CoV. Among 256 patients with comorbidities, 14 patients were confirmed for SARS-CoV. Conclusion: Clinical investigation in initial SARS-CoV-2 patients in the western Indian region revealed that young adult male was more susceptible than female. Symptoms such as fever, cough, and sore throat reports are useful for screening the SARS-CoV-2.
ABSTRACT
Allergic conjunctivitis （AC） is one of the most common eye diseases in ophthalmology， including type I allergies and type Ⅳallergies， which seriously affect the quality of life of patients. This article analyzes the current models of allergic conjunctivitis based on the characteristics of clinical symptoms of Chinese and Western medicine， including the types of animals selected， the characteristics of the models， and the analysis of the degree of agreement with the clinical symptoms of Chinese and Western medicine. It is concluded that most of the current AC model replication uses ovalbumin （OVA） induction method， ragweed pollen induction method. In recent years， animal models of fungal-inducible， compound 48/80-inducible， and murine allergic conjunctivitis have appeared， which are sensitized by the "systemic first and then local" method. Most of them have a high degree of coincidence with the characteristics of Western medicine symptoms， but there are certain gaps in the indicators of Chinese medicine， and there are also inconsistencies between the existing observation indicators and the diagnostic standards of Chinese medicine， resulting in unclear symptoms of Chinese medicine and irregular classification judgments. Therefore， To replicate the animal model with high clinical anastomosis of Chinese and Western medicine， further discussion and research are needed to better promote the research of allergic conjunctivitis.
ABSTRACT
This paper aimed to analyze the existing acne animal model based on the characteristics of acne clinical symptoms between Chinese and western medicine, in order to provide reference for the establishment of the rational acne animal model. Relevant literatures at home and abroad in recent years were reviewed to summarize the research progress of diagnostic criteria and drug treatment of acne with Chinese and western medicine, and analyze the existing acne animal model. The animal acne models were pathological models, and mainly reflected the clinical indicators of western medicine. Their evaluation was based on western medicine standard, with the standard of Chinese medicine for reference. More improved ideas and methods to establish acne animal models based on clinical study were put forward, so as to establish the reasonable quantitative standard for acne animal model. Furthermore, the animal model based on the combination of disease and syndrome was formed to provide a reliable experimental method for further study of acne. Rational acne animal model shall be selected according to the pathogenesis of acne, in order to improve the consistency between animal model and clinical symptoms, and lay a foundation for further study of acne.
ABSTRACT
Objective To investigate the efficacy and safety of levosimendan on patients with acute left heart failure in acute myocardial infarction.Methods Thirty patients with acute left heart failure in acute myocardial infarction were selected and treated with an initial loading dose of levosimendan of 0.05 μg/(kg · min),followed increasing dose to 0.20 μg/(kg · min) for 24 h after no adverse reactions were observed.Clinical assessment was performed to evaluate efficacy and safety of levosimendan.Results The scores of dyspnea before medication was (1.95 0.71),(1.49 ±0.56) scores at 24 hours after medication and (1.15 ±0.51) scores at 1 week after medication group,and the differences were significant(F =3.346,P=0.043).The scores of clinical manifestation was also different among before medication group ((1.87 ±-1.21) scores),24 hours after medication group((1.36 ± 0.61) scores) and 1 week after medication group ((1.09 ± 0.58) scores,F =5.203,P =0.024).After 1 week medication left ventricular ejection fraction (LVEF),stroke volume (SV) and plasma NT-proBNP had significant difference with before medication group (LVEF:before medication group:(30.41 ± 5.62) ％,1 week group:(43.16 ± 8.51) ％,t =2.238,P =0.037 ;SV:before medication group:(59.52 ± 25.23) ml,1 week group:(72.31 ± 14.91) ml,t =2.067,P =0.047 ;BNP:before medication group:(2 534.56 ± 1 570.23) rng/L,1 week group:(934.32 ± 421.53) ng/L,t=2.347,P =0.020).No severe adverse effects were seen during the course of medication,while the common adverse effects including palpitations,dizziness,hypotension and ventricular premature beats were remission after treatment.Conclusion Levosimendan treatment on acute myocardial infarction,heart failure is proved to be an efficacy,safety,and well tolerated.
ABSTRACT
"chi mi-byo (premorbidity) or zhi-weibing is defined as "preventive treatment of disease" in the "Annual Report on Health and Welfare 1997". In China, in the 2006 five-year plan for the "zhi-weibing" policy and in the 2008 "zhi-weibing" project, the policy has been changed in quality to emphasize prevention, "yo-jo or yangsheng (care of life)", and health for the purpose of improving lifestyle-related diseases and reducing the medical costs.<BR> The word "zhi-weibing" is used in "Suwen" and "Ling Shu" in reference the following: prevention, "yangsheng", and the initial/early treatment at the onset of disease. Additionally in "Nanjing" and "Jingui Yaolue", "zhi-weibing" means predicting the change of disease and preventing the progress of disease. Furthermore in Kampo Ikkando Medicine in Japan, it means improvement of constitution.<BR> In this symposium, I touched on the following: <BR>Volunteer activity reports at disaster areas<BR>Macroscopic viewpoint of current medical state (health issue in modern times)<BR>The relationship of health, disease, and the power to cure oneself<BR>"zhi-weibing or chi mi-byo"<BR>The world of Tao (way, path) and Mei (life)<BR>The "zhi-weibing" policy in China<BR>Symposiasts spoke on topics as follows: <BR> 1) Ascertaining the history of "zhi-weibing or chi mi-byo" and terminological issues like "chi mi-byo" or "mi-byo chi" in Japan<BR> 2) As a clinical practice of "chi mi-byo", an approach to a part of various methods of "yangsheng or yo-jo" based on the power to cure oneself and holistic healing method, the initial treatment, preventing the progress of disease, and the improvement of constitution<BR> 3)Achievement of the initial treatment of "Jingei-Kiko pulse diagnosis" and checking "the pulsation type and clinical condition"<BR>Whenever thinking about the future of the field of acupuncture and moxibustion, life quality of each and every human being, health, happiness, and medical economy, I would be much obliged if the contents of this "chi mi-byo" symposium are helpful to inspire medical care and the Society of Medicine, all healthcare professionals, and all patients.